
Validea's guru fundamental report indicates that UNITEDHEALTH GROUP INC (UNH) receives a 69% rating based on their Growth Investor model, which is based on the strategy of Martin Zweig. The model identifies UNH as a growth stock with accelerating earnings and sales growth, reasonable valuation, and low debt; however, the stock fails certain tests related to earnings persistence and long-term EPS growth.
UnitedHealth Group Inc. (UNH), a large-cap stock in the Insurance (Accident & Health) industry, scores 69% under Validea's Growth Investor model, based on Martin Zweig's strategy targeting growth stocks with accelerating earnings and sales, reasonable valuations, and low debt. This score is below the 80% threshold typically indicating model interest. UNH passes several criteria: its P/E ratio is acceptable, revenue growth is in line with EPS growth, sales growth rate is positive, and current quarter earnings show positive growth, surpassing both the prior three quarters and the historical growth rate. Insider transactions are also viewed positively. However, the analysis reveals significant weaknesses according to this specific model: UNH fails the tests for quarterly earnings compared to one year ago, the earnings growth rate over the past several quarters, overall earnings persistence, and long-term EPS growth. This mixed assessment indicates that while current growth momentum and valuation metrics are favorable, the lack of consistent, sustained earnings growth and weaker long-term EPS growth prospects temper the outlook from a Zweig-style growth investment perspective.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
-0.10
Ticker Sentiment